pennystockhaven
  • Facebook
  • Twitter
  • Youtube
  • Rss
Day-Trading Penny Stocks
  • Home
  • Services
  • Contact Us
Home» Commentary » Trading Idea with Catalyst Pharmaceutical Partners (NASDAQ:CPRX)

Trading Idea with Catalyst Pharmaceutical Partners (NASDAQ:CPRX)

Posted on January 6, 2013 by PennyStockHaven in Commentary, Stock Picks

Catalyst Pharmaceutical Partners (NASDAQ: CPRX) stock found a bottom after  sell-off (tax-losses) in the mid-December 2012 and now offers a solid trading opportunity.

CPRX annotated

Besides technical analysis, there are more reasons to join this trade:

  • CPRX announced on December 27th that it received a Nasdaq Staff Deficiency Letter for not compliance with the Minimum Bid Price requirement ($1/share) set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market. Catalyst noted that it will be able to regain compliance with the Rules within the allotted 180 days grace period.
  • Catalyst Pharmaceutical Partners (NASDAQ:CPRX) issued 6,666,667 shares at a conversion price of 75 cents/share of its unissued common stock to BioMarin Pharmaceutical (NASDAQ: BMRN) upon the automatic conversion of the $5 million loan that Catalyst received from BioMarin on October 26th.
  • CPRX has ~41MM+ shares outstanding with 2.5MM/shares short

CPRX logoCatalyst Pharmaceutical Partners, Inc.
355 Alhambra Circle, Suite 1500
Coral Gables, FL 33134
Tel: (305) 529-2522
Fax: (305) 529-0933

Catalyst is a speciality biopharmaceutical company focused on the de­vel­opment and commercialization of prescription drugs targeting diseases and disorders of the central nervous system (CNS), with a focus on the treatment of addiction, infantile spasms, epilepsy, and other CNS indications.

BMRN, CPRX

Search

Real Time Alerts:

Tweets by @PennyStockHaven

Updates

  • CVR Partners, LP (NYSE: UAN): the dividend play

    February 26, 2023
  • Sotera Health

    Sotera Health Company (NASDAQ:SHC): hard road ahead

    February 21, 2023
  • ZIM Integrated Shipping Services (NYSE:ZIM) uphill movement

    February 20, 2023
  • Carvana Co. (NYSE: CVNA) way to go… down

    February 17, 2023
  • ReWalk Robotics (RWLK): Yesterday, Today and Tomorrow

    June 8, 2019
  • Amyris, Inc. (AMRS): How to Mislead Investors

    April 21, 2019
  • ADMA Biologics, Inc. (ADMA): Offering is Imminent

    April 11, 2019
  • Proteostasis Therapeutics (PTI): Market Overreaction

    March 26, 2019
  • Dynagas LNG Partners LP (NYSE: DLNG) Coming Off Of Bottom

    February 1, 2019
  • Histogenics Corporation (HSGX) market: only upside from these levels

    September 5, 2018
  • Quantum Corp. (QTM): Appointed Jamie Lerner as Chief Executive Officer and President

    June 26, 2018
  • FuelCell Energy (NASDAQ:FCEL) A picture is worth a thousand words

    June 22, 2018

    Site

    • Home
    • Services
    • Contact Us
    • About Us
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    • Publishers

    Financial Network

    Yahoo Finance
    Reuters
    The Motley Fool
    WSJ
    CNBC
    Business Week
    The Street
    Bloomberg

    psh sloganYour Everything Penny Stocks Resource



    Copyright © 2021 PennyStockHaven.com. All Rights Reserved